These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26351167)
1. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line]. Wang D; Li YJ; Ding N; Wang JY; Yang Q; Yang YR; Li YM; Fang XD; Zhao H Yi Chuan; 2015 Jul; 37(7):673-82. PubMed ID: 26351167 [TBL] [Abstract][Full Text] [Related]
2. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
3. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells. Chung YH; Li SC; Kao YH; Luo HL; Cheng YT; Lin PR; Tai MH; Chiang PH Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829370 [TBL] [Abstract][Full Text] [Related]
4. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047 [TBL] [Abstract][Full Text] [Related]
5. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach. Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977 [TBL] [Abstract][Full Text] [Related]
6. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis. Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826 [TBL] [Abstract][Full Text] [Related]
7. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774 [TBL] [Abstract][Full Text] [Related]
8. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Larsen AC Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of basal microRNAs' patterns in human dental pulp stem cells. Vasanthan P; Govindasamy V; Gnanasegaran N; Kunasekaran W; Musa S; Abu Kasim NH J Cell Mol Med; 2015 Mar; 19(3):566-80. PubMed ID: 25475098 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
12. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer. Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189 [TBL] [Abstract][Full Text] [Related]
13. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes. Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053 [TBL] [Abstract][Full Text] [Related]
14. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553 [TBL] [Abstract][Full Text] [Related]
15. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma. Rang Z; Yang G; Wang YW; Cui F Biochem Biophys Res Commun; 2016 May; 474(2):315-320. PubMed ID: 27107696 [TBL] [Abstract][Full Text] [Related]
16. Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma. Polini B; Carpi S; Doccini S; Citi V; Martelli A; Feola S; Santorelli FM; Cerullo V; Romanini A; Nieri P Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867069 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. Zeljic K; Jovanovic I; Jovanovic J; Magic Z; Stankovic A; Supic G Ups J Med Sci; 2018 Mar; 123(1):43-49. PubMed ID: 29482431 [TBL] [Abstract][Full Text] [Related]
18. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas. Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Koutsaki M; Spandidos DA; Zaravinos A Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]